Navigation Links
Chindex International, Inc. to Present at 32nd Annual J.P. Morgan Healthcare Conference
Date:1/6/2014

BETHESDA, Md., Jan. 6, 2014 /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX), an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics, today announced that the Company will present at the 32nd Annual J.P. Morgan Healthcare Conference, to be held on January 13-16, 2014 at the Westin St. Francis Hotel in San Francisco. Management is scheduled to present at 9:30 a.m. PT on Wednesday, January 15, 2014, and to meet with institutional investors throughout the day.

For additional information, please contact your J.P. Morgan institutional sales representatives.

About Chindex International, Inc.

Chindex is an American healthcare company providing healthcare services in China through the operations of United Family Healthcare, a network of private primary care hospitals and affiliated ambulatory clinics. United Family Healthcare currently operates in Beijing, Shanghai, Tianjin, and Guangzhou. The Company also provides medical capital equipment and products through Chindex Medical Ltd., a joint venture company with manufacturing and distribution businesses serving both domestic China and export markets. With thirty years of experience, the Company's strategy is to continue its growth as a leading integrated healthcare provider in the Greater China region. Further company information may be found at the Company's website at http://www.chindex.com.

Contact: ICR, Inc.

William Zima'/>"/>

SOURCE Chindex International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Chindex International, Inc. to Report First Quarter 2012 Financial Results
2. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
3. Chindex International, Inc. to Announce Participation in Upcoming Investor Conferences
4. Chindex-Fosun Pharma Joint Venture, Chindex Medical, To Participate in Acquisition of Alma Lasers; Fosun Pharma Increases Investment in Chindex Medical
5. Chindex International, Inc. Reports First Quarter 2013 Financial Results
6. Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
8. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
9. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
10. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
11. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... 2015   Prime Therapeutics LLC (Prime), a ... members, today released the following statement responding to the ... first biosimilar to enter the U.S. market. ... of Sandoz,s Zarxio® to treat neutropenia, a condition affecting ... milestone in our country,s journey to curb the escalating ...
(Date:3/6/2015)... Solutions, Inc. (Pink Sheets: ASDS ) ("Ascendant" ... fourth quarter and year ended December 31, 2014. The ... than $0.01 per share, on revenues of $8,018,000 for ... net income of $195,000, or $0.01 per share, on ... The substantial increase in fourth quarter 2014 revenue was ...
(Date:3/6/2015)... TAMPA, Fla. , March 6, 2015 /PRNewswire/ ... received special validation from Intuitive Surgical, the manufacturer ... for their Triton-36 Instrument Cleaning System. This approval ... highest standards in cleanliness currently in place for ... this special validation for reprocessing robotic surgical instruments ...
Breaking Medicine Technology:Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 2Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 2Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 3Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 4Ascendant Solutions, Inc. Reports Fourth Quarter and Year End 2014 Earnings 5Ultra Clean Systems Reaches Exclusive Place within Robotic Surgical Instrument Cleaning Industry with Latest Certifications 2
... Inc. (Nasdaq: ENZN) announced today that four,posters containing ... Meeting of the American Association for Cancer Research,(AACR) ... 2007 in Los Angeles, CA., Details of the ... EZN-2208, a novel polyethyleneglycol-SN38,conjugate, has potent antitumor activity ...
... 13, 2007 - Point Therapeutics, Inc.,(NASDAQ: POTP) today ... 2007 Annual Meeting of the American,Association for Cancer ... 14-18, 2007. The AACR poster presentations report,on preclinical ... details for the AACR presentations are as,follows: , ...
Cached Medicine Technology:Enzon to Present Preclinical Data From PEG-SN38 and PEGylation,Technology Studies at AACR Meeting 2
(Date:3/6/2015)... 06, 2015 Follow us on ... most common forms of cancer and is the leading ... be screened through various techniques and tools, including mammography, ... the gold standard technique in breast cancer screening, driven ... taken for the procedure, required expertise to carry out ...
(Date:3/6/2015)... “On Tap” takes the audience on a journey ... the silver screen and to modern day rhythm tap. ... their famous eye-high kicks! Producers, directors and choreographers Mary Six ... dancing in this robust show, showcasing one of the only ... , “On Tap” is proud to host guest stars ...
(Date:3/6/2015)... 2015 As the Association of ... of 90,000 doctors by 2025 is updated this week ... (SH) is proactively preparing by analyzing demographics and pursuing ... , Several factors including the increasing number of ... under the Affordable Care Act and an uneven distribution ...
(Date:3/6/2015)... 2015 Jvion, the Atlanta-based leader ... a Clostridium Difficile (C Diff) predictive use case ... use case is the latest in a broad ... infections, chronic conditions, and individual illnesses. Using the ... solution flags at risk individuals to help support ...
(Date:3/6/2015)... Yisrayl Hawkins, Pastor and Overseer of ... a new publication explaining how micro-kingdoms keep the earth ... article titled “Microorganisms Do Much More Than You Think” ... were created and designed to keep all things functioning ... the functions of these micro-kingdom, but does not realize ...
Breaking Medicine News(10 mins):Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2
... which is angered by the defence attorneys of the AIIMS ... about the case where a boy, suffering from cancer, got ... 2001. ,The victim, who was nine years ... in July 2000 for treatment of cancer, supposedly has contracted ...
... the Human Fertilization and Embryology Authority show that recently ... opting for assisted reproduction technology// (ART) in the UK. ... of these women is 34. There is increase in ... for infertility. The doctors and scientists say that there ...
... new study, the antidepressant drug Zoloft (sertraline) may avoid ... also increase// the time interval between the depressive episodes. ... to background information in the study, reports foodconsumer.org. ... of age, who had recovered from depression during treatment ...
... the UK have been busy. They have tolled up 100,000 ... stop and control the spread of bird flu.// Researchers eleven ... they screened possible drug components that could be effective against ... the UK was originally built to help particle physicists examine ...
... A recent conducted at University of Michigan Health Systems ... have greater expectations of doom from their screening //mammography ... than not these expectations were unusually high or unrealistic. ... to an outpatient clinic for screening mammography. The participants ...
... the oldest mother in UK, from Lewes in East Sussex, ... fertility treatment. She gave the statement that this child had ... John Farrant made a joint statement, "We wish to emphasise ... without courage. A great deal of thought has been given ...
Cached Medicine News:Health News:A Boy Undergoing Treatment For Cancer Gets AIDS At AIIMS 2Health News:UK Computer Grid In Bird Flu Fight 2Health News:UK Computer Grid In Bird Flu Fight 3Health News:Most Women Have Unrealistic Expectations From Screening Mammography 2Health News:A mother at 63: oldest in UK! 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
Medicine Products: